NCT04189315View on ClinicalTrials.gov

Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic Disease

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Hypophosphatasia
Interventions
DRUG

asfotase alfa

Asfotase alfa is administered subcutaneously.

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY